| CASE REPORT |
|
| Year : 2019 | Volume
: 5
| Issue : 1 | Page : 34-37 |
|
|
Sorafenib-Induced Cutaneous Toxicities: Four Different Presentations
Pooja Bains, Saurabh Sharma
Department of Skin and V.D, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, Punjab, India
Correspondence Address:
Dr. Pooja Bains
Department of Skin and V.D, Sri Guru Ram Das Institute of Medical Sciences and Research, Sri Amritsar, Amritsar, Punjab
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijdd.ijdd_36_18
|
|
|
Sorafenib is a multikinase inhibitor which is used in the treatment of hepatocellular carcinoma and renal cell carcinoma. The cutaneous toxicities due to sorafenib can affect the daily activities of patients, resulting in interruption or dose modification of therapy. We report four cases of adverse cutaneous effects of sorafenib along with their management. The cases represent the wide spectrum of sorafenib cutaneous toxicities from mild to severe.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
